CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Gano Kyle Chief Executive Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,566 | 5,132 | ||
| 2025-02-13 | Gano Kyle Chief Executive Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,241 | 6,725 | ||
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +1,358 | 4,800 | ||
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −716 | $116.69 | $84K | 4,084 |
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +1,401 | 5,485 | ||
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −755 | $116.72 | $88K | 4,730 |
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,358 | 2,718 | ||
| 2025-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,401 | 4,203 | ||
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise 10b5-1 | +1,811 | 3,809 | ||
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −955 | $116.79 | $112K | 2,854 |
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise 10b5-1 | +1,541 | 4,395 | ||
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −830 | $116.69 | $97K | 3,565 |
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,811 | 3,623 | ||
| 2025-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,541 | 4,624 | ||
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +2,083 | 44,882 | ||
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −1,098 | $116.74 | $128K | 43,784 |
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +1,961 | 45,745 | ||
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −1,056 | $116.71 | $123K | 44,689 |
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,083 | 4,166 | ||
| 2025-02-13 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,961 | 5,885 |
Page 22 of 49 · 963 trades